Portland, OR, (June 18th, 2024) — EndoSound®, Inc., is thrilled to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) code, effective July 1, 2024, for the companies EndoSound Vision System™, or EVS™, a revolutionary advancement in endoscopic ultrasound (EUS) technology.
The CMS TPT status is monumental as it provides outpatient facilities with an incremental Medicare payment for procedures in which the EVS is utilized. This status is granted to new and innovative medical devices that meet eligibility criteria. Pass-through payments are intended to help facilitate patient access to new technologies. Details on the TPT code, C1606, can be found in the July 2024 update of the hospital outpatient prospective payment system, which is accessible on the CMS website.
“We are incredibly proud to receive the TPT status from CMS for the EVS,” said Scott Aldrich, CEO of EndoSound. “This approval underscores the clinical value and innovative nature of our technology. It enables broader access to the benefits of EUS, which is critical for early detection and treatment of gastrointestinal diseases. Our goal is to improve patient outcomes while reducing healthcare costs, and this milestone brings us a big step closer to achieving that.”
The EVS is an innovative, cost-effective solution designed to enhance the capabilities of existing endoscopic equipment, providing high-resolution ultrasound imaging without the need for expensive and complex new scopes. This breakthrough technology promises to improve the accessibility and quality of care for patients undergoing EUS procedures.
EndoSound remains committed to advancing medical technology and improving patient access to care.
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. EndoSound is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
In partnership with Modo, Inc., we designed our EVSTM Cart to optimize convenience and stability. We are excited to share that this innovative design was recognized as a 2024 iF Design Award winner.
More than 10,000 entries were received from companies headquartered worldwide for the annual design competition. We hope this cart will play a valuable role in the endoscopy suite, saving time and maximizing workflow, and we are proud to be among this year’s selection of iF Design winners.
Past winners include Apple, Nikon, Siemens Healthineers, Philips, BMW Samsung, Google, and Canon Inc.
Aldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth
Portland, Feb 6, 2024—EndoSound® Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (Nasdaq: MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer.
Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical device imaging. Furthermore, Mr. Aldrich is a seasoned executive with experience in startup organizations, as well as, small/mid cap companies that are both privately and publicly held. He has established a reputation as an authentic leader with the ability to drive execution through clear organizational vision.
Mr Aldrich remarked, “I am honored and humbled to be able to assume the role of CEO. Stephen has done a remarkable job in getting EndoSound so far in its journey. EndoSound EVS™ is a customer-focused product that can reduce aggregate healthcare costs and improve patient experience and lives. It is exciting to be bringing this technology that so clearly can transform the GI market and patient access to endoscopic ultrasound to market. I look forward to working closely with the EndoSound Board of Directors, Stephen, and the rest of the EndoSound team in successfully launching EVS and making the company’s immense potential a reality.”
Stephen Steinberg, MD, commented, “We are thrilled to welcome Scott to the team. He brings a wealth of knowledge in areas that will be extremely important to EndoSound’s success. We believe his leadership style, business acumen and passion make him more than capable to build and grow a revolutionary medical device company.”
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. It is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
https://www.endosound.com/wp-content/uploads/2024/02/EndoSound_Appoints_Aldrich-2.webp6421703Mariano Francohttp://www.endosound.com/wp-content/uploads/2023/08/Endosound-New-web-logo-no-tag2023.pngMariano Franco2024-02-29 05:05:162024-05-30 11:42:32EndoSound® Inc., appoints medical device commercial leader Scott Aldrich Jr as Chief Executive Officer
EndoSound Vision System™ Granted Transitional CMS Pass-Through Code
Company NewsPortland, OR, (June 18th, 2024) — EndoSound®, Inc., is thrilled to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) code, effective July 1, 2024, for the companies EndoSound Vision System™, or EVS™, a revolutionary advancement in endoscopic ultrasound (EUS) technology.
The CMS TPT status is monumental as it provides outpatient facilities with an incremental Medicare payment for procedures in which the EVS is utilized. This status is granted to new and innovative medical devices that meet eligibility criteria. Pass-through payments are intended to help facilitate patient access to new technologies. Details on the TPT code, C1606, can be found in the July 2024 update of the hospital outpatient prospective payment system, which is accessible on the CMS website.
The EVS is an innovative, cost-effective solution designed to enhance the capabilities of existing endoscopic equipment, providing high-resolution ultrasound imaging without the need for expensive and complex new scopes. This breakthrough technology promises to improve the accessibility and quality of care for patients undergoing EUS procedures.
EndoSound remains committed to advancing medical technology and improving patient access to care.
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. EndoSound is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
To learn more about the EVS, please visit endosound.com/endosound-vision-system
For media inquiries, please contact:
Patrick Hurley
VP of Marketing
pr@endosound.com
EVS™ Cart Receives 2024 iF Design Award
Company NewsIn partnership with Modo, Inc., we designed our EVSTM Cart to optimize convenience and stability. We are excited to share that this innovative design was recognized as a 2024 iF Design Award winner.
More than 10,000 entries were received from companies headquartered worldwide for the annual design competition. We hope this cart will play a valuable role in the endoscopy suite, saving time and maximizing workflow, and we are proud to be among this year’s selection of iF Design winners.
Past winners include Apple, Nikon, Siemens Healthineers, Philips, BMW Samsung, Google, and Canon Inc.
Learn more about the EVS cart and system.
EndoSound® Inc., appoints medical device commercial leader Scott Aldrich Jr as Chief Executive Officer
Company NewsAldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth
Portland, Feb 6, 2024—EndoSound® Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (Nasdaq: MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer.
Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical device imaging. Furthermore, Mr. Aldrich is a seasoned executive with experience in startup organizations, as well as, small/mid cap companies that are both privately and publicly held. He has established a reputation as an authentic leader with the ability to drive execution through clear organizational vision.
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. It is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
To learn more about the EVS, please visit endosound.com/endosound-vision-system
For media inquiries, please contact:
Patrick Hurley
VP of Marketing
pr@endosound.com